Abstract
The protein database has > 450 entries with P450 in the title and of these there are approximately 54 unique structures. Although this sample of unique structures is small relative to the large number of P450s in Nature, it now is clear that the overall P450-fold is highly conserved and restricted to P450s and a small handful of other heme–thiolate enzymes. These crystal structures exhibit adaptations that underlie interactions with specific protein partners and in eukaryotes contribute to membrane binding. A handful of structures now have been solved in both the substrate-free open and substrate-bound closed states, and, while the details may differ among P450s, the open/close motion is very similar and involves the same elements of secondary structure. While the open form is more flexible, and thus may sample a number of isoenergetic conformations, highly specific P450s have only one unique substrate-bound conformation. In sharp contrast, for drug-metabolizing P450s, those regions most important for the open/close equilibrium also can adapt to substrates of different sizes, shapes, and chemical properties and is a unique design feature of these nonspecific P450s. Critical to understanding precisely how and which regions are most adaptable in drug-metabolizing P450s are the increasing number of ligand-bound structures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Poulos TL, Finzel BC, Gunsalus IC, Wagner GC, Kraut J (1985) The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem 260:16122–16130
Poulos TL, Finzel BC, Howard AJ (1987) High-resolution crystal structure of cytochrome P450cam. J Mol Biol 195:687–700
Ravichandran KG, Boddupalli SS, Hasermann CA, Peterson JA, Deisenhofer J (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450’s. Science 261:731–736
Shimizu H, Park SY, Shiro Y, Adachi S (2002) X-ray structure of nitric oxide reductase (cytochrome P450nor) at atomic resolution. Acta Crystallogr D Biol Crystallogr 58:81–89
Shoun H, Sudo Y, Seto Y, Beppu T (1983) Purification and properties of a cytochrome P-450 of a fungus, Fusarium oxysporum. J Biochem 94:1219–1229
Chiang CW, Yeh HC, Wang LH, Chan NL (2006) Crystal structure of the human prostacyclin synthase. J Mol Biol 364:266–274
Hecker M, Ullrich V (1989) On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem 264:141–150
Li L, Chang Z, Pan Z, Fu ZQ, Wang X (2008) Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase. Proc Natl Acad Sci U S A 105:13883–13888
Brash AR (2009) Mechanistic aspects of CYP74 allene oxide synthases and related cytochrome P450 enzymes. Phytochemistry 70:1522–1531
Song WC, Brash AR (1991) Purification of an allene oxide synthase and identification of the enzyme as a cytochrome P-450. Science 253:781–784
Lee DS, Nioche P, Hamberg M, Raman CS (2008) Structural insights into the evolutionary paths of oxylipin biosynthetic enzymes. Nature 455:363–368
Lee DS, Yamada A, Sugimoto H, Matsunaga I, Ogura H, Ichihara K, Adachi S, Park SY, Shiro Y (2003) Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies. J Biol Chem 278:9761–9767
Belcher J, McLean KJ, Matthews S, Woodward LS, Fisher K, Rigby SEJ, Nelson DR, Potts D, Baynham MT, Parker DA, Leys D, Munro AW (2014) Structure and biochemical properties of the alkene producing cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp. 8456 bacterium. J Biol Chem 289:6535–6550
Sundaramoorthy M, Terner J, Poulos TL (1995) The crystal structure of chloroperoxidase: a heme peroxidase–cytochrome P450 functional hybrid. Structure 3:1367–1377
Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Stuehr DJ, Tainer JA (1998) Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279:2121–2126
Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC (1999) Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol 6:233–242
Raman CS, Li H, Martasek P, Kral V, Masters BS, Poulos TL (1998) Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95:939–950
Adman E, Watenpaugh KD, Jensen LH (1975) NH—S hydrogen bonds in Peptococcus aerogenes ferredoxin, Clostridium pasteurianum rubredoxin, and Chromatium high potential iron protein. Proc Natl Acad Sci U S A 72:4854–4858
Ueyama N, Nishikawa N, Yamada Y, Okamura T, Nakamura A (1996) Cytochrome P-450 model (porphinato)(thiolatio)iron(III) complexes with and double NH-S hydrogen bonds. J Am Chem Soc 118:1286–1287
Ueyama N, Terakawa T, Nakata M, Nakamura A (1983) Positive shift of redox potential of [Fe2S4(Z-cys-Gly-Ala-OMe)4]2− in dichloromethane. J Am Chem Soc 105:7098–7102
Poulos TL, Finzel BC (1984) Heme enzyme structure and function. In: Mearn MT (ed) Peptide and protein reviews. Marcel Dekker, New York, pp 115–171
Doeff MA, Sweigart DA, O’Brien P (1983) Hydrogen bonding from coordinated imidazole in ferric porphyrin complexes. Effect on the iron(III)/iron(II) reduction potential. Inorg Chem 22:851–852
Banci L, Bertini I, Pease EA, Tien M, Turano P (1992) 1H NMR investigation of manganese peroxidase from Phanerochaete chrysosporium. A comparison with other peroxidases. Biochemistry 31:10009–10017
Chang CK, Traylor TG (1973) Proximal base influence on the binding of oxygen and carbon monoxide to heme. J Am Chem Soc 95:8477–8479
Nappa M, Valentine JS, Snyder PA (1977) Imidazolate complexes of ferric porphyrins. J Am Chem Soc 99:5799–5800
Valentine JS, Sheridan RP, Allen LC, Kahn PC (1979) Coupling between oxidation state and hydrogen bond conformation in heme proteins. Proc Natl Acad Sci U S A 76:1009–1013
Cupp-Vickery JR, Poulos TL (1995) Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat Struct Biol 2:144–153
Meharenna YT, Li H, Hawkes DB, Pearson AG, De Voss J, Poulos TL (2004) Crystal structure of P450cin in a complex with its substrate, 1,8-cineole, a close structural homologue to D-camphor, the substrate for P450cam. Biochemistry 43:9487–9494
Benson DE, Suslick KS, Sligar SG (1997) Reduced oxy intermediate observed in D251N cytochrome P450cam. Biochemistry 36:5104–5107
Denisov IG, Makris TM, Sligar SG, Schlichting I (2005) Structure and chemistry of cytochrome P450. Chem Rev 105:2253–2277
Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG (2000) The catalytic pathway of cytochrome p450cam at atomic resolution. Science 287:1615–1622
Vidakovic M, Sligar SG, Li H, Poulos TL (1998) Understanding the role of the essential Asp251 in cytochrome P450cam using site-directed mutagenesis, crystallography, and kinetic solvent isotope effect. Biochemistry 37:9211–9219
Nagano S, Poulos TL (2005) Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism. J Biol Chem 280:31659–31663
Nagano S, Cupp-Vickery JR, Poulos TL (2005) Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF. J Biol Chem 280:22102–22107
Cupp-Vickery JR, Han O, Hutchinson CR, Poulos TL (1996) Substrate-assisted catalysis in cytochrome P450eryF. Nat Struct Biol 3:632–637
Omura T, Ito A (1991) Biosynthesis and intracellular sorting of mitochondrial forms of cytochrome P450. Methods Enzymol 206:75–81
Sakaguchi M, Omura T (1993) Topology and biogenesis of microsomal cytochrome P-450s. In: Ruckpaul K, Rein H (eds) Medicinal implications in cytochrome P-450 catalyzed biotransformations. Akademie, Berlin, pp 59–73
White SH, Ladokhin AS, Jayasinghe S, Hristova K (2001) How membranes shape protein structure. J Biol Chem 276:32395–32398
Andersen OS, Koeppe RE (2007) Bilayer thickness and membrane protein function: an energetic perspective. Annu Rev Biophys Biomol Struct 36:107–130
Von Wachenfeldt C, Richardson TH, Cosme J, Johnson EF (1997) Microsomal P450 2C3 is expressed as a soluble dimer in Echerichia coli following modifications of its N-terminus. Arch Biochem Biophys 339:107–114
Cosme J, Johnson EF (2000) Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding. J Biol Chem 275:2545–2553
Andersen JF, Hutchinson CR (1992) Characterization of Saccharopolyspora erythraea cytochrome P-450 genes and enzymes, including 6-deoxyerythronolide B hydroxylase. J Bacteriol 174:725–735
Koga H, Sagara Y, Yaoi T, Tsujimura M, Nakamura K, Sekimizu K, Makino R, Shimada H, Ishimura Y, Yura K, et al (1993) Essential role of the Arg112 residue of cytochrome P450cam for electron transfer from reduced putidaredoxin. FEBS Lett 331:109–113
Pernecky SJ, Larson JR, Philpot RM, Coon MJ (1993) Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 in Escherichia coli: influence of NH 2-terminal region on localization in cytosol and membranes. Proc Natl Acad Sci U S A 90:2651–2655
Johnson EF, Stout CD (2013) Structural diversity of eukaryotic membrane cytochrome P450s. J Biol Chem 288:17082–17090
Ghosh D, Griswold J, Erman M, Pangborn W (2009) Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 457:219–223
Lo J, Di NG, Griswold J, Egbuta C, Jiang W, Gilardi G, Ghosh D (2013) Structural basis for the functional roles of critical residues in human cytochrome P450 aromatase. Biochemistry 52:5821–5829
Yamamoto K, Gildenberg M, Ahuja S, Im SC, Pearcy P, Waskell L, Ramamoorthy A (2013) Probing the transmembrane structure and topology of microsomal cytochrome-P450 by solid-state NMR on temperature-resistant bicelles. Sci Rep 3:2556
Monk BC, Tomasiak TM, Keniya MV, Huschmann FU, Tyndall JD, O’Connel J,Cannon RD, McDonald JG, Rodriguez A, Finer-Moore JS, Stroud RM (2014) Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci U S A 111:3865–3870
Williams PA, Cosme J, Sridhar V, Johnson EF, McRee DE (2000) The crystallographic structure of a mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell 5:121–132
Williams PA, Cosme J, Sridhar V, Johnson EF, McRee DE (2000) Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. J Inorg Biochem 81:183–190
Denisov IG, Shih AY, Sligar SG (2012) Structural differences between soluble and membrane bound cytochrome P450s. J Inorg Biochem 108:150–158
De Lemos-Chiarandini C, Frey AB, Sabatini DD, Kreibich G (1987) Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies. J Cell Biol 104:209–219
Von Wachenfeldt C, Johnson EF (1995) Structures of eukaryotic cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 2nd edn. Plenum Press, New York, pp 183–244
Bayburt TH, Sligar SG (2002) Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc Natl Acad Sci U S A 99:6725–6730
Shank-Retzlaff ML, Raner GM, Coon MJ, Sligar SG (1998) Membrane topology of cytochrome P450 2B4 in langmuir-blodgett monolayers. Arch Biochem Biophys 359:82–88
Cojocaru V, Balali-Mood K, Sansom MS, Wade RC (2011) Structure and dynamics of the membrane-bound cytochrome P450 2C9. PLoS Comput Biol 7:e1002152
Berka K, Hendrychova T, Anzenbacher P, Otyepka M (2011) Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site. J Phys Chem A 115:11248–11255
Berka K, Paloncyova M, Anzenbacher P, Otyepka M (2013) Behavior of human cytochromes P450 on lipid membranes. J Phys Chem B 117:11556–11564
Baylon JL, Lenov IL, Sligar SG, Tajkhorshid E (2013) Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation. J Am Chem Soc 135:8542–8551
Ohta Y, Kawato S, Tagashira H, Takemori S, Kominami S (1992) Dynamic structures of adrenocortical cytochrome P-450 in proteoliposomes and microsomes: protein rotation study. Biochemistry 31:12680–12687
Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H (2004) Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 305:683–686
Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, Johnson EF (2004) Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem 279:9497–9503
Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2007) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem 282:14348–14355
Ozalp C, Szczesna-Skorupa E, Kemper B (2006) Identification of membrane-contacting loops of the catalytic domain of cytochrome P450 2C2 by tryptophan fluorescence scanning. Biochemistry 45:4629–4637
Davydov DR (2011) Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions. Expert Opin Drug Metab Toxicol 7:543–558
Szczesna-Skorupa E, Mallah B, Kemper B (2003) Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells. J Biol Chem 278:31269–31276
Hu G, Johnson EF, Kemper B (2010) CYP2C8 exists as a dimer in natural membranes. Drug Metab Dispos 38:1976–1983
Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA (2011) Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J Biol Chem 286:5607–5613
Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW (2011) Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci U S A 108:10139–10143
Strushkevich N, Gilep AA, Shen L, Arrowsmith CH, Edwards AM, Usanov SA, Park HW (2013) Structural insights into aldosterone synthase substrate specificity and targeted inhibition. Mol Endocrinol 27:315–324
Annalora AJ, Goodin DB, Hong WX, Zhang Q, Johnson EF, Stout CD (2010) The crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. J Mol Biol 396:441–451
Murtazina D, Puchkaev AV, Schein CH, Oezguen N, Braun W, Nanavati A, Pikuleva IA (2002) Membrane-protein interactions contribute to efficient 27-hydroxylation of cholesterol by mitochondrial cytochrome P450 27A1. J Biol Chem 277:37582–37589
Headlam MJ, Wilce MC, Tuckey RC (2003) The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. Biochim Biophys Acta 1617:96–108
Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM (2006) Crystal structure of human cytochrome P450 2D6. J Biol Chem 281:7614–7622
Nakayama K, Puchkaev A, Pikuleva IA (2001) Membrane binding and substrate access merge in cytochrome P450 7A1, a key enzyme in degradation of cholesterol. J Biol Chem 276:31459–31465
Poulos TL, Finzel BC, Howard AJ (1986) Crystal structure of substrate-free Pseudomonas putida cytochrome P450. Biochemistry 25:5314–5322
Li H, Poulos TL (1997) The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat Struct Biol 4:140–146
Haines DC, Tomchick DR, Machius M, Peterson JA (2001) Pivotal role of water in the mechanism of P450BM-3. Biochemistry 40:13456–13465
Li H, Poulos TL (1995) Modeling protein substrate interactions in the heme domain of cytochrome P450BM-3. Acta Crystallogr D 51:21–32
Paulsen MD, Ornstein RL (1995) Dramatic differences in the motions of the mouth of open and closed cytochrome P450BM-3 by molecular dynamics simulations. Proteins 21:237–243
Lee YT, Wilson RF, Rupniewski I, Goodin DB (2010) P450cam visits an open conformation in the absence of substrate. Biochemistry 49:3412–3419
Hays AM, Dunn AR, Chiu R, Gray HB, Stout CD, Goodin DB (2004) Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires. J Mol Biol 344:455–469
Lee Y-T, Glazer EC, Wilson RF, Stout CD, Goodin DB (2011) Three clusters of conformational states in P450cam reveal a multistep pathway for closing of the substrate access channel. Biochemistry 50:693–703
Yang W, Bell SG, Wang H, Zhou W, Hoskins N, Dale A, Bartlam M, Wong L-L, Rao Z (2010) Molecular characterization of a class I P450 electron transfer system from Novosphingobium aromaticivorans DSM1(2444). J Biol Chem 285:27372–27384
Yang W, Bell SG, Wang H, Zhou W, Bartlam M, Wong L-L, Rao Z (2010) The structure of CYP101D2 unveils a potential path for substrate entry into the active site. Biochem J 433:85–93
Vohra S, Musgaard M, Bell S, Wong LL, Zhou W, Biggin PC (2013) The dynamics of camphor in the cytochrome P450 CYP101D2. Protein Sci 22:1218–1229
Batabyal D, Poulos TL (2013) Crystal structures and functional characterization of wild-type CYP101D1 and its active site mutants. Biochemistry 52:8898–8906
Gay SC, Shah MB, Talakad JC, Maekawa K, Roberts AG, Wilderman PR, Sun L, Yang JY, Huelga SC, Hong WX, Zhang Q, Stout CD, Halpert JR (2010) Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution. Mol Pharmacol 77:529–538
Shah MB, Wilderman PR, Pascual J, Zhang Q, Stout CD, Halpert JR (2012) Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry 18:7225–7238
Zhao Y, White MA, Muralidhara BK, Sun L, Halpert JR, Stout CD (2006) Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction. J Biol Chem 281:5973–5981
Scott EE, He YA, Wester MR, White MA, Chin CC, Halpert JR, Johnson EF, Stout CD (2003) An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution. Proc Natl Acad Sci U S A 100:13196–13201
Cojocaru V, Winn PJ, Wade RC (2007) The ins and outs of cytochrome P450s. Biochim Biophys Acta 1770:390–401
Modi S, Sutcliffe MJ, Primrose WU, Lian LY, Roberts GC (1996) The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction. Nat Struct Biol 3:414–417
Nagano S, Li H, Shimizu H, Nishida C, Ogura H, Ortiz de Montellano PR, Poulos TL (2003) Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK. J Biol Chem 278:44886–44893
Bower S, Perkins JB, Yocum RR, Howitt CL, Rahaim P, Pero J (1996) Cloning, sequencing, and characterization of the Bacillus subtilis biotin biosynthetic operon. J Bacteriol 178:4122–4130
Cryle MJ, De Voss JJ (2004) Carbon-carbon bond cleavage by cytochrome p450(BioI)(CYP107H1). Chem Commun (Camb) 86–87
Cryle MJ, Matovic NJ, De Voss JJ (2003) Products of cytochrome P450(BioI) (CYP107H1)-catalyzed oxidation of fatty acids. Org Lett 5:3341–3344
Cryle MJ, Schlichting I (2008) Structural insights from a P450 carrier protein complex reveal how specificity is achieved in the P450(BioI) ACP complex. Proc Natl Acad Sci U S A 105:15696–15701
Zhao B, Lei L, Vassylyev DG, Lin X, Cane DE, Kelly SL, Yuan H, Lamb DC, Waterman MR (2009) Crystal structure of albaflavenone monooxygenase containing a moonlighting terpene synthase active site. J Biol Chem 284:36711–36719
Miller DJ, Allemann RK (2012) Sesquiterpene synthases: passive catalysts or active players? Nat Prod Rep 29:60–71
Akhtar M, Wright JN, Lee-Robichaud P (2011) A review of mechanistic studies on aromatase (CYP19) and 17alpha-hydroxylase-17,20-lyase (CYP17) J Steroid Biochem Mol Biol 125:2–12
Mast N, White MA, Bjorkhem I, Johnson EF, Stout CD, Pikuleva IA (2008) Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain. Proc Natl Acad Sci U S A 105:9546–9551
Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park HW (2008) Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 380:95–106
Ghosh D, Griswold J, Erman M, Pangborn W (2010) X-ray structure of human aromatase reveals an androgen-specific active site. J Steroid Biochem Mol Biol 118:197–202
Zhao B, Lei L, Kagawa N, Sundaramoorthy M, Banerjee S, Nagy LD, Guengerich FP, Waterman MR (2012) Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants. J Biol Chem 287:10613–10622
DeVore NM, Scott EE (2012) Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001. Nature 482:116–119
Strushkevich N, Usanov SA, Park HW (2010) Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol 397:1067–1078
Lepesheva GI, Hargrove TY, Anderson S, Kleshchenko Y, Furtak V, Wawrzak Z, Villalta F, Waterman MR (2010) Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi. J Biol Chem 285:25582–25590
Walsh AA, Szklarz GD, Scott EE (2013) Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 288:12932–12943
Wang A, Savas U, Stout CD, Johnson EF (2011) Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1. J Biol Chem 286:5736–5743
Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-Å resolution. J Biol Chem 279:38091–38094
Ekroos M, Sjogren T (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci U S A 103:13682–13687
Porubsky PR, Meneely KM, Scott EE (2008) Structures of human cytochrome P450 2E1: insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. J Biol Chem 283:33698–33707
Porubsky PR, Battaile KP, Scott EE (2010) Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode. J Biol Chem 285:22282–22290
Yano JK, Hsu MH, Griffin KJ, Stout CD, Johnson EF (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol 12:822–823
Smith BD, Sanders JL, Porubsky PR, Lushington GH, Stout CD, Scott EE (2007) Structure of the human lung cytochrome P450 2A13. J Biol Chem 282:17306–17313
Williams PA, Cosme J, Ward A, Angove HC, Matak VD, Jhoti H (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424:464–468
Wester MR, Yano JK, Schoch GA, Yang C, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human microsomal cytochrome P450 2C9 complexed with flurbiprofen at 2.0 Å resolution. J Biol Chem 279:35630–35637
Reynald RL, Sansen S, Stout CD, Johnson EF (2012) Structural characterization of human cytochrome P450 2C19: active site differences between P450’s 2C8, 2C9 and 2C19. J Biol Chem 287:44581–44591
Wang A, Savas U, Hsu MH, Stout CD, Johnson EF (2012) Crystal structure of human cytochrome P450 2D6 with prinomastat bound. J Biol Chem 287:10834–10843
Sevrioukova IF, Li H, Zhang H, Peterson JA, Poulos TL (1999) Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A 96:1863–1868
Sevrioukova IF, Hazzard JT, Tollin G, Poulos TL (1999) The FMN to heme electron transfer in cytochrome P450BM-3. Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site. J Biol Chem 274:36097–36106
Sevrioukova IF, Immoos CE, Poulos TL, Farmer P (2000) Electron transfer in the ruthenated heme domain of cytochrome P450BM-3. Isr J Chem 40:47–53
Adamovich TB, Pikuleva IA, Chashchin VL, Usanov SA (1989) Selective chemical modification of cytochrome P-450SCC lysine residues. Identification of lysines involved in the interaction with adrenodoxin. Biochim Biophys Acta 996:247–253
Coghlan VM, Vickery LE (1991) Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc. J Biol Chem 266:18606–18612
Wada A, Waterman MR (1992) Identification by site-directed mutagenesis of two lysine residues in cholesterol side-chain cleavage cytochrome P450 that are essential for adrenodoxin binding. J Biol Chem 267:22877–22882
Hiruma Y, Hass MA, Kikui Y, Liu WM, Olmez B, Skinner SP, Blok A, Kloosterman A, Koteishi H, Lohr F, Schwalbe H, Nojiri M, Ubbink M (2013) The structure of the cytochrome P450cam-putidaredoxin complex determined by paramagnetic NMR spectroscopy and crystallography. J Mol Biol. http://www.ncbi.nlm.nih.gov/pubmed/23856620
Tripathi S, Li H, Poulos TL (2013) Structural basis for effector control and redox partner recognition in cytochrome P450. Science 340:1227–1230
Lipscomb JD, Sligar SG, Namtvedt MJ, Gunsalus IC (1976) Autooxidation and hydroxylation reactions of oxygenated cytochrome P-450cam. J Biol Chem 251:1116–1124
Sligar SG, Debrunner PG, Lipscomb JD, Namtvedt MJ, Gunsalus IC (1974) A role of the putidaredoxin COOH-terminus in P-450cam (cytochrome m) hydroxylations. Proc Natl Acad Sci U S A 71:3906–3910
Tyson CA, Lipscomb JD, Gunsalus IC (1972) The role of putidaredoxin and P450 cam in methylene hydroxylation. J Biol Chem 247:5777–5784
Pochapsky TC, Lyons TA, Kazanis S, Arakaki T, Ratnaswamy G (1996) A structure-based model for cytochrome P450cam-putidaredoxin interactions. Biochimie 78:723–733
Geren L, Tuls J, O’Brien P, Millett F, Peterson JA (1986) The involvement of carboxylate groups of putidaredoxin in the reaction with putidaredoxin reductase. J Biol Chem 261:15491–15495
Imai M, Shimada H, Watanabe Y, Matsushimahibiya Y, Makino R, Koga H, Horiuchi T, Ishimura Y (1989) Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine–a possible role of the hydroxy amino-acid in oxygen activation. Proc Natl Acad Sci U S A 86:7823–7827
Kuznetsov VY, Poulos TL, Sevrioukova IF (2006) Putidaredoxin-to-cytochrome P450cam electron transfer: differences between the two reductive steps required for catalysis. Biochemistry 45:11934–11944
Unno M, Shimada H, Toba Y, Makino R, Ishimura Y (1996) Role of Arg112 of cytochrome P450cam in the electron transfer from reduced putidaredoxin. Analyses with site-directed mutants. J Biol Chem 271:17869–17874
Shimada H, Nagano S, Hori H, Ishimura Y (2001) Putidaredoxin-cytochrome P450cam interaction. J Inorg Biochem 83:255–260
Unno M, Christian JF, Sjodin T, Benson DE, Macdonald ID, Sligar SG, Champion PM (2002) Complex formation of cytochrome P450cam with putidaredoxin. Evidence for protein-specific interactions involving the proximal thiolate ligand. J Biol Chem 277:2547–2553
Nagano S, Shimada H, Tarumi A, Hishiki T, Kimata-Ariga Y, Egawa T, Suematsu M, Park SY, Adachi S, Shiro Y, Ishimura Y (2003) Infrared spectroscopic and mutational studies on putidaredoxin-induced conformational changes in ferrous CO-P450cam. Biochemistry 42:14507–14514
Shiro Y, Iizuka T, Makino R, Ishimura Y, Morishima I (1989) N-15 NMR-Study on cyanide (C-15n-) complex of cytochrome-P-450cam–Effects of D-camphor and putidaredoxin on the iron ligand structure. J Am Chem Soc 111:7707–7711
Tosha T, Yoshioka S, Ishimori K, Morishima I (2004) L358P mutation on cytochrome P450cam simulates structural changes upon putidaredoxin binding: the structural changes trigger electron transfer to oxy-P450cam from electron donors. J Biol Chem 279:42836–42843
Tosha T, Yoshioka S, Takahashi S, Ishimori K, Shimada H, Morishima I (2003) NMR study on the structural changes of cytochrome P450cam upon the complex formation with putidaredoxin. Functional significance of the putidaredoxin-induced structural changes. J Biol Chem 278:39809–39821
Pochapsky SS, Pochapsky TC, Wei JW (2003) A model for effector activity in a highly specific biological electron transfer complex: the cytochrome P450(cam)-putidaredoxin couple. Biochemistry 42:5649–5656
Zhang W, Pochapsky SS, Pochapsky TC, Jain NU (2008) Solution NMR structure of putidaredoxin-cytochrome P450cam complex via a combined residual dipolar coupling-spin labeling approach suggests a role for Trp106 of putidaredoxin in complex formation. J Mol Biol 384:349–363
OuYang B, Pochapsky SS, Dang M, Pochapsky TC (2008) A functional proline switch in cytochrome P450cam. Structure 16:916–923
Glascock MC, Ballou DP, Dawson JH (2005) Direct observation of a novel perturbed oxyferrous catalytic intermediate during reduced putidaredoxin-initiated turnover of cytochrome P-450-CAM: probing the effector role of putidaredoxin in catalysis. J Biol Chem 280:42134–42141
Unno M, Christian JF, Benson DE, Gerber NC, SLigar SG, Champion PM (1997) Resonance Raman investigations of cytochrome P450cam complexed with putidaredoxin. J Am Chem Soc 119:6614–6620
Davies MD, Qin L, Beck JL, Suslick KS, Koga H, Horiuchi T, Sligar SG (1990) Putidaredoxin reduction of cytochrome P-450cam–dependence of electron-transfer on the identity of putidaredoxins C-terminal amino-acid. J Am Chem Soc 112:7396–7398
Davies MD, Sligar SG (1992) Genetic variants in the putidaredoxin-cytochrome P-450cam electron-transfer complex: identification of the residue responsible for redox-state-dependent conformers. Biochemistry 31:11383–11389
Holden M, Mayhew M, Bunk D, Roitberg A, Vilker V (1997) Probing the interactions of putidaredoxin with redox partners in camphor P450 5-monooxygenase by mutagenesis of surface residues. J Biol Chem 272:21720–21725
Pochapsky T, Lyons TA, Kazanis S, Arakaki T, Ratnaswamy G (1996) A structure-based model for cytochrome P450cam-putidaredoxin interactions. Biochimie 78:723–733
Stayton PS, Sligar SG (1991) Structural microheterogeneity of a tryptophan residue required for efficient biological electron transfer between putidaredoxin and cytochrome P-450cam. Biochemistry 30:1845–1851
Gerber NC, Sligar SG (1994) A role for Asp-251 in cytochrome P-450cam oxygen activation. J Biol Chem 269:4260–4266
Stok JE, Yamada S, Farlow AJ, Slessor KE, De Voss JJ (2013) Cytochrome P450(cin) (CYP176A1) D241N: investigating the role of the conserved acid in the active site of cytochrome P450s. Biochim Biophys Acta 1834:688–696
Bridges A, Gruenke L, Chang YT, Vakser IA, Loew G, Waskell L (1998) Identification of the binding site on cytochrome P450 2B4 for cytochrome 5 and cytochrome P450 reductase. J Biol Chem 273:17036–17049
Kleywegt GJ, Jones TA (1994) Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr D Biol Crystallogr 50:178–185
Acknowledgments
TLP would like to thank members of the UCI P450 group, Dipanwita Batabyal, Huiying Li, Irina Sevrioukova, and Sarvind Tripathi, as well as NIH grant GM32688. EFJ would like to thank his colleagues at TSRI, Mei Hsu, Ying Fan, and C. David Stout, as well as the support of NIH Grant GM031001.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Poulos, T., Johnson, E. (2015). Structures of Cytochrome P450 Enzymes. In: Ortiz de Montellano, P. (eds) Cytochrome P450. Springer, Cham. https://doi.org/10.1007/978-3-319-12108-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-12108-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12107-9
Online ISBN: 978-3-319-12108-6
eBook Packages: MedicineMedicine (R0)